Disc Medicine, Inc.: management transactions · United States · SEC (Form 4) Browse the full insider trade history of Disc Medicine, Inc., a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €2.7bn. The latest transaction was filed on 26 August 2025 (Cession). Among the most active insiders: Savage William Jacob. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 26 August 2025
All Executives96 Thresholds0 Prospectus0 Other0
Declarations 96 total
▼ Director · Executives · 22 Aug 2025
2,287 shares @ US$61.03 0.6% of flow Common Stock SEC:0001415889-25-023049:0
▼ Director · Executives · 18 Jul 2025
664 shares @ US$61.13 0.2% of flow Common Stock SEC:0001415889-25-020127:0
◇ Chief Executive Officer · Executives · 3 Jul 2025
5,200 shares @ US$9.86 5.6% of flow Common Stock SEC:0000950170-25-094695:0
▼ Chief Executive Officer · Executives · 3 Jul 2025
5,200 shares @ US$55.0874 31.4% of flow Common Stock SEC:0000950170-25-094695:1
▼ Chief Medical Officer · Executives · 20 May 2025
6,677 shares @ US$50.0417 24.6% of flow Common Stock SEC:0000950170-25-076525:0
▼ Chief Medical Officer · Executives · 2 May 2025
2,100 shares @ US$50.1748 7.8% of flow Common Stock SEC:0000950170-25-064843:0
◇ Chief Executive Officer · Executives · 7 Apr 2025
7,000 shares @ US$1.01 0.8% of flow Common Stock SEC:0000950170-25-052289:0
▼ Director · Executives · 24 Mar 2025
1,956 shares @ US$54.11 0.5% of flow Common Stock SEC:0000947871-25-000345:0
▼ Director · Executives · 24 Mar 2025
1,956 shares @ US$54.11 0.5% of flow Common Stock SEC:0000947871-25-000346:0
▼ Director · Executives · 19 Mar 2025
13,517 shares @ US$54.02 3.5% of flow Common Stock SEC:0000947871-25-000333:0
▼ Director · Executives · 19 Mar 2025
13,517 shares @ US$54.02 3.5% of flow Common Stock SEC:0000947871-25-000334:0
▼ Director · Executives · 10 Mar 2025
68,766 shares @ US$54.29 17.9% of flow Common Stock SEC:0000947871-25-000308:0
▼ Director · Executives · 10 Mar 2025
68,766 shares @ US$54.29 17.9% of flow Common Stock SEC:0000947871-25-000309:0
▼ Chief Medical Officer · Executives · 18 Feb 2025
1,638 shares @ US$54.58 7.1% of flow Common Stock SEC:0000950170-25-024474:0
▼ Chief Financial Officer · Executives · 18 Feb 2025
3,136 shares @ US$54.58 100.0% of flow Common Stock SEC:0000950170-25-024472:0
▼ Chief Operating Officer · Executives · 18 Feb 2025
1,610 shares @ US$54.58 100.0% of flow Common Stock SEC:0000950170-25-024473:0
▼ Chief Executive Officer · Executives · 18 Feb 2025
5,574 shares @ US$54.58 37.5% of flow Common Stock SEC:0000950170-25-024471:0
▼ Chief Legal Officer · Executives · 18 Feb 2025
1,161 shares @ US$54.58 12.7% of flow Common Stock SEC:0000950170-25-024476:0
▼ Chief Commercial Officer · Executives · 18 Feb 2025
3,137 shares @ US$54.58 100.0% of flow Common Stock SEC:0000950170-25-024477:0
◆ Chief Operating Officer · Executives · 10 Feb 2025
24,000 shares 0Common Stock SEC:0000950170-25-019094:0
◆ Chief Executive Officer · Executives · 10 Feb 2025
78,337 shares 0Common Stock SEC:0000950170-25-019089:0
◆ Chief Commercial Officer · Executives · 10 Feb 2025
36,000 shares 0Common Stock SEC:0000950170-25-019106:0
◇ Chief Medical Officer · Executives · 3 Feb 2025
4,233 shares @ US$2.65 0.9% of flow Common Stock SEC:0000950170-25-019085:0
◆ Chief Legal Officer · Executives · 10 Feb 2025
24,000 shares 0Common Stock SEC:0000950170-25-019101:0
◆ Chief Financial Officer · Executives · 10 Feb 2025
36,000 shares 0Common Stock SEC:0000950170-25-019092:0
25 of 96 declarations
Load more (71 remaining)